Already positive, the research from UBS and its analyst Andre Kukhnin still consider the stock as a Buy opportunity. Previously set at EUR 207, the target price has been raised to EUR 250.
In a research note, UBS analyst Andre Kukhnin has maintained his recommendation on the stock with a Buy rating. The target price remains unchanged at EUR 207.
Analyst Andre Kukhnin from UBS research considers the stock attractive and recommends it with a Buy rating. The target price remains unchanged at EUR 207.